318010.KQ Pharmsville Co. Ltd
- Market cap
- KRW 26.2B
- P/E
- 8.6x
- P/B
- 0.39x
- ROE
- 5.0%
- Dividend yield
- 2.95%
- Fundamental score
- 2.9/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 318010.KQ undervalued?
Graham number318010.KQ trades 61.1% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pharmsville Co. Ltd fundamental analysis
15 of 22 checks passedROE 0/2
Low return on equity (5.0%), below 10%.
ROA 1/1
Return on assets (4.9%) is above the industry median (1.4%).
Profit Consistency 2/2
Profitable for 9 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (82.5%) is above the 5-year average (0.3% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (82.5%) is above the industry median (1.8%).
Revenue Growth 0/2
Revenue shrank 21.3% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
EBIT is 5,646.8x against interest expense, well covered.
PE vs Market 1/1
PE (8.6x) is below the market median (11.3x).
PE vs Industry 1/1
PE (8.6x) is below the industry median (11.4x).
PBV 1/1
Price to book (0.4x) is below the industry median (0.9x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 3.4, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 30.44, above 1.
Dividend Yield 1/2
Dividend yield (2.9%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 1/2
Dividends paid without a cut of more than 10% for 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 26.8%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Pharmsville Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pharmsville Co. Ltd
Pharmsville Co., Ltd. produces and sells functional health food in South Korea. The company also exports its products. It offers its products under the Apple Tree Dr. Kim, Devil Diet, Sang Sang Bang, Vitamin Story, Apple Tree, Golden Garden, Daily Green, Wilac, Doctor Solution, and PS brands. Pharmsville Co., Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Full company profilePharmsville Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pharmsville Co. Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 16.8B | 19.8B | 30.0B | 39.4B | 39.0B | 26.1B | 21.4B | 16.7B | 12.7B | 9.74B |
| Gross Profit | 12.3B | 14.7B | 22.3B | 27.4B | 25.8B | 15.8B | 13.2B | 10.5B | 8.06B | 6.40B |
| Operating Income | 4.10B | 5.49B | 7.11B | 4.31B | 6.16B | 4.06B | 1.63B | -671M | -673M | -435M |
| EBITDA | - | - | - | - | - | 6.02B | 4.79B | 2.55B | 4.23B | 4.55B |
| Net Income | 3.67B | 4.84B | 7.26B | 2.89B | 5.00B | 4.06B | 3.31B | 1.58B | 2.89B | 3.34B |
| EPS | 1,528 | 1,920 | 915 | 369 | 637 | 518 | 427 | 205 | 374 | 433 |
| Balance Sheet | ||||||||||
| Total Assets | 28.9B | 33.5B | 67.8B | 69.0B | 74.3B | 74.8B | 71.3B | 67.1B | 68.5B | 68.4B |
| Total Liabilities | 9.84B | 6.55B | 12.4B | 13.4B | 15.1B | 12.3B | 7.37B | 2.62B | 1.95B | 1.66B |
| Shareholders' Equity | 19.1B | 26.9B | 55.4B | 55.7B | 59.2B | 62.6B | 63.9B | 64.5B | 66.4B | 66.6B |
| Cash & Short-term Investments | 11.4B | 14.3B | 39.1B | 36.3B | 41.7B | 42.8B | 39.5B | 37.7B | 1.67B | 4.91B |
| Total Debt | 6.40B | 1.34B | 4.42B | 8.00B | - | - | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 4.38B | 5.07B | 5.66B | 68.7M | 8.27B | 5.20B | 4.65B | -347M | 1.89B | 2.11B |
| Capital Expenditure | 228M | 1.20B | 6.59B | 3.53B | 291M | 120M | 293M | 105M | 70.5M | 337M |
| Free Cash Flow | - | - | - | -3.48B | 7.95B | 5.06B | 4.36B | -452M | 1.82B | 1.78B |
| Ratios | ||||||||||
| ROE | 19.2% | 18.0% | 13.1% | 5.2% | 8.4% | 6.5% | 5.2% | 2.5% | 4.3% | 5.0% |
| ROA | 12.7% | 14.5% | 10.7% | 4.2% | 6.7% | 5.4% | 4.6% | 2.4% | 4.2% | 4.9% |
| Net Profit Margin | 21.8% | 24.4% | 24.2% | 7.3% | 12.8% | 15.6% | 15.5% | 9.5% | 22.7% | 34.3% |
| Debt to Equity | 0.34x | 0.05x | 0.08x | 0.14x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Pharmsville Co. Ltd dividends
- Dividend yield
- 2.95%
- Forward dividend
- 200.00 KRW
- Payout ratio
- 26.8%
- Ex-dividend date
- Dec 29, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 773M | 100 | 26.8% |
| 2024 | KRW 775M | 100 | 49.0% |
| 2023 | KRW 785M | 101 | 23.7% |
| 2022 | KRW 785M | 100 | 19.3% |
| 2021 | KRW 785M | 100 | 15.7% |
| 2020 | KRW 1.59B | 202 | 54.8% |
| 2019 | KRW 252M | 32 | 3.5% |
| 2018 | KRW 240M | 95 | 5.0% |
| 2017 | KRW 120M | 50 | 3.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Pharmsville Co. Ltd
- Insiders 75.74%
- Institutions 0.00%
- Public & others 24.26%
- Shares outstanding 7.73M
- Free float 1.99M
Pharmsville Co. Ltd company profile
- Company name
- Pharmsville Co. Ltd
- Ticker
- 318010.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 18
- Fiscal year end
- December
- Address
- 37 Magok Jungang, Seoul, South Korea
- Phone
- 82 2 553 1323
- Website
- pharmsville.net
About Pharmsville Co. Ltd
Pharmsville Co., Ltd. produces and sells functional health food in South Korea. The company also exports its products. It offers its products under the Apple Tree Dr. Kim, Devil Diet, Sang Sang Bang, Vitamin Story, Apple Tree, Golden Garden, Daily Green, Wilac, Doctor Solution, and PS brands. Pharmsville Co., Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Pharmsville Co. Ltd management
1- Mr. Byungwook LeeCEO & Inside Director · born 1962